Filing Flows › Myriad Genetics (MYGN) › Prenatal Health revenue
Myriad Genetics (MYGN) Prenatal Health revenue by quarter
Myriad Genetics' Prenatal Health revenue was $39.3M in Q3 2026 (third quarter 2026), -1% from Q2 2026. Over the last 3 quarters it ranged from $39.3M (Q3 2026) to $41.9M (Q1 2026).
| Quarter | Prenatal Health revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $39.3M | -1% | — |
| Q2 2026 | $39.8M | -5% | — |
| Q1 2026 | $41.9M | — | — |
Q3 2026 at a glance
Myriad Genetics, Q3 2026: revenue $203M (-2% year over year), operating margin -19.7%, net loss $43.9M, operating cash flow −$6.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Myriad Genetics' Prenatal Health revenue?
Myriad Genetics' Prenatal Health revenue was $39.3M in Q3 2026 (third quarter 2026), -1% from Q2 2026.
How has Myriad Genetics' Prenatal Health revenue changed?
Over the last 3 quarters it ranged from $39.3M (Q3 2026) to $41.9M (Q1 2026).